Cargando…
Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias
Large granular lymphocytes (LGLs) are large lymphocytes with azurophilic granules in their cytoplasm. LGLs are either natural killer (NK) cells or T lymphocytes. Expansions of the LGLs in the peripheral blood are seen in various conditions, including three clonal disorders: T-cell LGL (T-LGL) leukem...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548667/ https://www.ncbi.nlm.nih.gov/pubmed/28717070 http://dx.doi.org/10.2169/internalmedicine.56.8881 |
_version_ | 1783255849540517888 |
---|---|
author | Oshimi, Kazuo |
author_facet | Oshimi, Kazuo |
author_sort | Oshimi, Kazuo |
collection | PubMed |
description | Large granular lymphocytes (LGLs) are large lymphocytes with azurophilic granules in their cytoplasm. LGLs are either natural killer (NK) cells or T lymphocytes. Expansions of the LGLs in the peripheral blood are seen in various conditions, including three clonal disorders: T-cell LGL (T-LGL) leukemia, chronic lymphoproliferative disorders of NK cells (CLPD-NK), and aggressive NK-cell leukemia (ANKL). However, the monoclonal and polyclonal expansion of LGLs has been associated with many other conditions. The present article describes these LGL disorders, with special emphasis on the clinical features, pathogenesis, and treatments of the three above-mentioned clonal disorders. |
format | Online Article Text |
id | pubmed-5548667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-55486672017-08-11 Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias Oshimi, Kazuo Intern Med Review Article Large granular lymphocytes (LGLs) are large lymphocytes with azurophilic granules in their cytoplasm. LGLs are either natural killer (NK) cells or T lymphocytes. Expansions of the LGLs in the peripheral blood are seen in various conditions, including three clonal disorders: T-cell LGL (T-LGL) leukemia, chronic lymphoproliferative disorders of NK cells (CLPD-NK), and aggressive NK-cell leukemia (ANKL). However, the monoclonal and polyclonal expansion of LGLs has been associated with many other conditions. The present article describes these LGL disorders, with special emphasis on the clinical features, pathogenesis, and treatments of the three above-mentioned clonal disorders. The Japanese Society of Internal Medicine 2017-07-15 /pmc/articles/PMC5548667/ /pubmed/28717070 http://dx.doi.org/10.2169/internalmedicine.56.8881 Text en Copyright © 2017 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Oshimi, Kazuo Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias |
title | Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias |
title_full | Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias |
title_fullStr | Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias |
title_full_unstemmed | Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias |
title_short | Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias |
title_sort | clinical features, pathogenesis, and treatment of large granular lymphocyte leukemias |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548667/ https://www.ncbi.nlm.nih.gov/pubmed/28717070 http://dx.doi.org/10.2169/internalmedicine.56.8881 |
work_keys_str_mv | AT oshimikazuo clinicalfeaturespathogenesisandtreatmentoflargegranularlymphocyteleukemias |